Grauer Andreas bought SGMT
April 20, 2026 · Form 4 insider transaction
Grauer Andreas bought 264,759 shares of Sagimet Biosciences Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 24 days after the transaction.
Direction
Acquired (buy-side)
Shares
264,759
Price
$0.00
Total value
N/A
InsiderGrauer Andreas
Role—
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateApril 20, 2026
Filing dateMay 14, 2026
Shares owned after264,759
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
25% of the shares underlying this option shall vest and become exercisable on April 20, 2027, with the remaining 75% vesting over thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.